Related Experiment Video
Updated: Aug 8, 2026
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 19, 2013
Effects of transferrin-indium on cellular proliferation of a human leukemia cell line
1University of Colorado Health Sciences Center, Denver 80262.
Insights
Transferrin-bound indium significantly inhibits cell proliferation by impairing iron uptake, a mechanism distinct from simple indium salts. This suggests a targeted approach for cancer therapy by disrupting cellular iron metabolism.
Area of Science:
- Cell Biology
- Biochemistry
- Metal Toxicology
Background:
- Transferrin-gallium inhibits cellular proliferation by impairing iron utilization.
- Indium, a Class 3A metal, has not been extensively studied for its effects on cellular processes.
- Transferrin is crucial for iron uptake in cells.
Purpose of the Study:
- To investigate the effects of indium, when bound to transferrin, on cellular iron uptake and proliferation.
- To compare the antiproliferative effects of transferrin-bound indium versus indium salts.
- To elucidate the mechanism by which transferrin-indium affects cellular iron metabolism.
Main Methods:
- Cell culture exposed to varying concentrations of transferrin-indium and indium salts.
- Measurement of cellular iron uptake and transferrin receptor expression.
- Utilizing a monoclonal antibody against the transferrin receptor to block iron uptake.
Main Results:
- Transferrin-bound indium demonstrated a 50-fold greater inhibition of cellular proliferation compared to indium salts.
- Cells treated with transferrin-indium showed increased transferrin receptor expression but reduced iron incorporation.
- A monoclonal antibody against the transferrin receptor inhibited proliferation, with a synergistic effect when combined with transferrin-indium.
Conclusions:
- Transferrin-bound indium effectively inhibits cellular proliferation, likely by disrupting the release of iron from transferrin after cellular uptake.
- The mechanism involves increased transferrin receptor expression and a subsequent defect in iron utilization.
- These findings suggest potential therapeutic applications for transferrin-indium in targeting cellular proliferation.
Abstract:
In previous studies, we have demonstrated that transferrin-gallium inhibits cellular proliferation by a mechanism whereby cellular iron utilization is impaired. Since indium, a similar class 3A metal, has not been well studied, we examined its effects on cellular iron uptake and cellular proliferation. In these studies, we provide evidence that indium, when bound to transferrin, has a 50-fold higher effect on inhibition of cellular proliferation than indium added as indium salt. Cells exposed to relatively low concentrations of transferrin-indium exhibit markedly increased transferrin receptor expression but, as with transferrin-gallium, these cells incorporate an inappropriately low amount of iron, suggesting that there is a defect in the release of internalized iron from transferrin. In further studies, we utilize a monoclonal antibody against transferrin receptor that inhibits transferrin-mediated iron uptake. This antibody exhibits a dose-related inhibition of cellular proliferation, and when both transferrin-indium and monoclonal antibody are added to media, there is a more than additive effect on inhibition of cellular proliferation.
